Erlanger joins clinical trial aiming to reduce stroke in atrial fibrillation patients

Submitted by Erlanger Health System
Posted 9/23/21

CHATTANOOGA – Erlanger Health System announces the Erlanger Heart and Lung Institute is participating in a clinical trial studying if blood thinners are more effective at preventing stroke in …

This item is available in full to subscribers.

Please log in to continue

Log in